Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. (Q64140078)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. |
clinical trial |
Statements
REALISE (English)
0 references
A Multicenter Phase II, Open Label, Single Arm Study to Evaluate the Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients. (English)
0 references
31 March 2017
0 references
24 July 2018
0 references
51
0 references
18 year
0 references